Form 4: Simulations Plus Director Walter Woltosz and Virginia Woltosz Execute Stock Sales and Receive Stock Grant

Sentiment:

SEC Form 4


Walter S. Woltosz and Virginia E. Woltosz, both directors and 10% owners of Simulations Plus, Inc., executed sales of common stock under a Rule 10b5-1 plan and received a stock grant as independent director compensation.

Summary

  • Walter S. Woltosz and Virginia E. Woltosz, both directors and 10% owners of Simulations Plus, Inc., reported transactions involving the company's common stock on February 3, 2025.
  • The transactions included sales of common stock at prices ranging from $32.86 to $34.22, executed automatically under a pre-arranged Rule 10b5-1 plan.
  • Walter S. Woltosz sold 5,579 shares at an average price of $33.53 and 14,421 shares at an average price of $34.06.
  • Additionally, Walter S. Woltosz acquired 787 shares as independent director compensation under the company's 2021 Equity Incentive Plan at $0.
  • Following these transactions, Walter S. Woltosz beneficially owns 3,403,371 shares of Simulations Plus, Inc.

Sentiment

Score: 5

Explanation: The sentiment is neutral. The document primarily reports transactions, with no explicit positive or negative commentary. The sales are pre-planned, mitigating potential negative interpretations.

Positives

  • Walter S. Woltosz received 787 shares as compensation, indicating continued involvement with the company as an independent director.

Negatives

  • The sales of shares by a director and 10% owner could be interpreted negatively by some investors, although the sales were pre-planned under a Rule 10b5-1 plan.

Risks

  • While the sales were conducted under a 10b5-1 plan, large sales by insiders can sometimes create short-term price volatility.

Industry Context

Insider transactions are common and closely watched in the financial industry as they can provide insights into management's perspective on the company's valuation and future prospects. Rule 10b5-1 plans are often used to mitigate concerns about insider trading.

Stakeholder Impact

  • The stock sales could have a minor impact on shareholder sentiment, although the existence of a 10b5-1 plan should reassure investors that the sales were pre-planned and not based on inside information.

Key Dates

DateDescription
02/03/2025Date of stock sales and stock grant.
02/04/2025Date of signature for the Form 4 filing.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.